Although HER2 expression and/or amplification exhibited no link with patient’s gender, age, tumor size, or tumor differentiation, significant correlations with depth of invasion, lymph node metastasis, TNM staging, vascular invasion and metastasis were observed (Table 1). This evidence concerns the gene ERBB2 and neoplasm.